Mike Oliphant, PhD
mike-oli.bsky.social
Mike Oliphant, PhD
@mike-oli.bsky.social
Pinned
1st Job Posting! Open-Rank Research Assistant positions (Entry to Senior) in the Oliphant Lab! Join me in beautiful Colorado to study tumor initiation, metabolic reprogramming & drug resistance in breast cancer using patient-derived organoids & multiomic approaches!

cu.taleo.net/careersectio...
Laboratory Sciences Professional (Open Rank: Entry to Senior)
Click the link provided to see the complete job description.
cu.taleo.net
1st Job Posting! Open-Rank Research Assistant positions (Entry to Senior) in the Oliphant Lab! Join me in beautiful Colorado to study tumor initiation, metabolic reprogramming & drug resistance in breast cancer using patient-derived organoids & multiomic approaches!

cu.taleo.net/careersectio...
Laboratory Sciences Professional (Open Rank: Entry to Senior)
Click the link provided to see the complete job description.
cu.taleo.net
July 2, 2025 at 7:41 PM
Lastly, I’d be remiss if I didn’t acknowledge that although things are changing, I have hope that we can get through it and be stronger for it!
March 5, 2025 at 3:26 PM
A special shoutout to the @hmsbpa.bsky.social for providing such a strong and supportive community throughout my time at @harvardmed.bsky.social @harvardcellbio.bsky.social!
March 5, 2025 at 3:26 PM
I wouldn’t be where I am today without the guidance and support of my incredible mentors. A heartfelt thank you to Joan Brugge, Senthil Muthuswamy, @heidefordlab.bsky.social Heide Ford, and Jo Ann Cameron for your time, wisdom, and for fostering my growth as a scientist.
March 5, 2025 at 3:24 PM
Plz help spread the word—I’ll be hiring at all levels and will post job openings soon!
March 5, 2025 at 3:24 PM
I’m geeked to share that I’ll be starting my lab at the
@cuanschutz.bsky.social @cupharmacology.bsky.social
on July 1st! The Oliphant (Oli) Lab will leverage multi-omics approaches & organoid models to advance our understanding of breast cancer evolution, metabolic reprogramming & drug resistance
March 5, 2025 at 3:24 PM